Compare Asiaplast Industries Tbk (APLI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Asiaplast Industries Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Asiaplast Industries Tbk trades at Rp246 (market cap 340.67B, 113.6K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp152 (market cap 556.95B, 60.83M 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (60.83M versus 113.6K). Which is the better fit depends on your goals.
| APLI | LABS | |
|---|---|---|
Market Cap | 340.67B | 556.95B |
Volume | 113.6K | 60.83M |
Lot | 1.14K | 608.34K |
Turnover | 28.08M | 10.26B |
Average Price | 247.19 | 168.64 |
Value | 28.08M | 10.26B |
Indicative Equilibrium Price | 250 | 152 |
Indicative Equilibrium Volume | 100 | 4.52K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Asiaplast Industries Tbk
PT. Asiaplast Industries Tbk, formerly PT. Akasa Pandukarya and originally known as PT. Adi Karya Perkasa. The company started its commercial operations in 1994. Since November 1999, the company started to produce PVC synthetic leather. As of December 31, 2000, the Company has five production lines comprising of production lines I, II and III, which are used for producing PVC plastic sheets, with production capacity of 15,000 tons per year (un audited) and production lines IV, V, which are used for producing synthetic leather, with production capacity of 6, 500 tons per year (un audited). The Capital Investment Coordinating Board has approved the change of the Companys status from foreign capital investment to become domestic capital investment based on the letter No. 24/1/IP/I/PMDN/2015 dated February 18, 2015.
Read more on APLI →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
